CHU Lille

Running trials

• Not yet recruiting

  Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study

  NCT07376447· Source

• Not yet recruiting

  Efficacy and Safety Evaluation of iNstroke 5F Aspiration Catheter for Thrombectomy

  NCT07571954· Source

• Not yet recruiting

  Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.

  NCT07568782· Source

• Not yet recruiting

  Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung Cancer

  NCT07828938· Source

• Recruiting

  Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease

  NCT07274254· Phase 3· Source

• Not yet recruiting

  Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers

  NCT07437287· Phase 2/3· Source

• Not yet recruiting

  Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor

  NCT07471425· Source

• Recruiting

  Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease

  NCT07627763· Source

• Not yet recruiting

  Factors Associated With Blood Pressure Control Failure to Intravenous Labetalol in Severe Preeclampsia

  NCT07547046· Source

• Recruiting

  Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis

  NCT07388992· Source

• Recruiting

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  NCT07322003· Phase 3· Source

• Recruiting

  LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.

  NCT07202897· Phase 3· Source

• Enrolling by invitation

  the REMONO-CD and the REMONO-UC Studies

  NCT07564609· Source

• Recruiting

  Evaluation of the Safety of Electrical Spinal Cord Stimulation in Parkinson's Patients Presenting With Painful Camptocormia

  NCT06291051· Source

• Recruiting

  CongenItal Naevus Cohort for Longitudinal Evaluation

  NCT06828822· Source

• Not yet recruiting

  Early-phase Telecare Programs for Minor Stroke

  NCT06306144· Source

• Recruiting

  Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease

  NCT06925061· Phase 2· Source

• Recruiting

  Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

  NCT06571149· Phase 4· Source

• Recruiting

  Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.

  NCT05879276· Phase 3· Source

• Recruiting

  Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data

  NCT06380192· Source

• Recruiting

  Personalized Medicine for Advanced Biliary Cancer Patients

  NCT05615818· Phase 3· Source

• Recruiting

  Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

  NCT06427304· Source

• Recruiting

  Incidence of Major Complication in Case of Thoracic Aortic Aneurysm

  NCT05395598· Source

• Recruiting

  Treatment Resistant Depression and Vagus Nerve Stimulation

  NCT05952674· Source

• Recruiting

  Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor

  NCT06083129· Phase 3· Source

• Recruiting

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Source

• Recruiting

  Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology

  NCT05625724· Phase 3· Source

• Active, not recruiting

  Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

  NCT05825573· Phase 3· Source

• Recruiting

  Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)

  NCT05521776· Source

• Recruiting

  Pulmonary Vein Isolation Alone or in Combination With Substrate Modulation After Electric Cardioversion Failure

  NCT05264831· Source

• Recruiting

  Medico-economic Evaluation Rehabilitation by Serious Games at Home for the Management of Patients With Parkinson's Disease Suffering From Gait and Balance Disorders

  NCT04720365· Source

• Recruiting

  Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults

  NCT05157685· Phase 3· Source

• Recruiting

  INSIGHTFUL-FFR Clinical Trial

  NCT05437900· Phase 4· Source

• Recruiting

  Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study

  NCT04935853· Source

• Not yet recruiting

  Impact of Allo-HSCT on Bone Remodeling: Evolution of Bone Mineral Density and Architecture Measured by Bone Densitometry

  NCT05161026· Source

• Recruiting

  Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma

  NCT04749108· Phase 2/3· Source

• Recruiting

  Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

  NCT04477681· Source

• Recruiting

  Natural History of Duchenne Muscular Dystrophy

  NCT03882827· Source

• Active, not recruiting

  Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)

  NCT04602091· Source

• Active, not recruiting

  Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)

  NCT02767063· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke4 recruiting
• Liver and biliary tract cancer3 recruiting
• Acute myeloid leukemia2 recruiting
• Crohn's disease2 recruiting
• Heart failure2 recruiting
• High blood pressure2 recruiting
• Parkinson disease2 recruiting
• ALS (motor neurone disease)1 recruiting
• Amyloidosis1 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• COPD1 recruiting
• Coronary artery disease1 recruiting
• Depression1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Epilepsy1 recruiting
• Glioblastoma1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Lung cancer1 recruiting
• Multiple sclerosis1 recruiting
• Neuroendocrine tumours1 recruiting
• Osteoporosis1 recruiting
• Sickle cell disease1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib Dose Titration to 4.5 mg/kg/day versus Placebo in the Treatment of Patients with Primary Progressive or Secondary Progressive Multiple Sclerosis Without Relapse

  2024-516672-16-00· Phase 3· Source

• Completed

  A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

  NCT05383170· Phase 1/2· Source

• Completed

  Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

  NCT05308966· Source

• Completed

  Consequences of COVID 19 Pandemic on Childhood Asthma

  NCT04821908· Source

• Completed

  Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)

  NCT04590144· Source

• Completed

  Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

  NCT04753749· Source

• Terminated

  Study of New Mutations in Cone Disorders

  NCT04658251· Source

• Completed

  A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

  NCT04374136· Phase 3· Source

• Completed

  Haemophilia and Bone Loss - PHILEOS Study

  NCT04384341· Source

• Completed

  Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) in FLT3-ITD AML Patients

  NCT03690115· Phase 2· Source

• Terminated

  Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.

  NCT03312075· Source

• Completed

  Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

  NCT04069468· Source

• Completed

  Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility

  NCT07164924· Source